Trump, amid COVID-19 response, touts new insulin savings program esagonowsky Wed, 05/27/2020 – 09:58 More: Trump, amid COVID-19 response, touts new insulin savings program Source: fierce
read moreNovartis’ repurposed leukemia drug tops Sanofi’s Aubagio in MS study weeks ahead of FDA verdict arlene.weintraub Wed, 05/27/2020 – 09:36 More: Novartis' repurposed leukemia drug tops Sanofi's Aubagio in MS study weeks ahead of FDA verdict Source: fierce
read moreThe Defeat Diabetes includes a number of initiatives to provide access to affordable care to vulnerable patients and accelerate prevention to halt the rise of the disease More: Novo Nordisk launches social responsibility strategy for diabetes Source: News
read moreIn patients with liver metastases, Kisqali combination therapy cut the risk of death by 47% and 37% in two trials More: New analysis shows survival benefit of Novartis' Kisqali Source: News
read moreEvidence from trials suggests that tumours with NTRK gene fusions shrink in response to larotrectinib More: NICE issues final guidance on NHS use of Bayer's Vitrakvi Source: News
read moreThe group will work on two experimental vaccines and an antiviral More: MSD unveils bid to tackle coronavirus pandemic Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals